Close Menu

NEW YORK – Molecular diagnostics instrument and assay maker Rheonix has received an expanded Emergency Use Authorization from the US Food and Drug Administration for its SARS-CoV-2 assay. The firm's test is now authorized for the use of saliva samples.

Ithaca, New York-based Rheonix obtained its initial EUA for a SARS-Cov-2 test in April.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.